Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BIOA compared with DRUG: revenue, margins and what each company keeps, and the suppliers and customers both name
BIOA
BioAge Labs, Inc.
Change
Mkt cap
Revenue
Revenue
DRUG
Bright Minds Biosciences Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
BIOA
BioAge Labs, Inc.
vs
DRUG
Bright Minds Biosciences Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
BIOA, solid
DRUG, dashed
Supply-chain overlap
Revenue flow
BIOA: latest quarter is a loss; flow not drawable. DRUG: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only BIOA
0
None
Shared
0
No disclosed counterparties: BIOA.
Only DRUG
11
—
Gerep Realty
unlisted
supplier
—
Technology Innovation Center
unlisted
supplier
—
ZoE Life Fulton Labs Incubator
unlisted
supplier
—
Dr. Cunningham lab
unlisted
supplier
7 more · DRUG chain
›
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
BIOA
BioAge Labs, Inc.
Change
5.89
▼
−0.84%
· post 5.87
Mkt cap
$263.2M
Revenue
$2M
Q2 FY26
Revenue
$9M
FY25
DRUG
Bright Minds Biosciences Inc.
Change
54.98
▼
−3.01%
· post 54.98
Closed
Oct 30 '26
Mkt cap
$419.8M
Revenue
—
Revenue
—
vs
Compare
Closed
Oct 30 '26
BIOA
BioAge Labs, Inc.
vs
DRUG
Bright Minds Biosciences Inc.
5.89
▼
−0.84%
post 5.87
Price
54.98
▼
−3.01%
post 54.98
$263.2M
Mkt cap
$419.8M
Q2 FY26
$2M
Revenue
—
FY25
$9M
Revenue
—
Change
Change
BIOA
5.89
▼
−0.84%
vs
DRUG
54.98
▼
−3.01%
Closed
Oct 30 '26